Skip to main content
SpringerLink
Log in

Human Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum

  • Original Articles
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

Serum amyloid P component (SAP) is a universal constituent of amyloid deposits and contributes to their pathogenesis. SAP also has important normal functions in the handling of chromatin in vivo and resistance to bacterial infection. The atomic resolution crystal structure of SAP is known, but its physiological oligomeric assembly remains controversial. In the absence of calcium, isolated human SAP forms stable decamers composed of two cyclic disk-like pentamers interacting face to face. However, in the presence of its specific low molecular weight ligands and calcium, SAP forms stable pentamers. In the presence of calcium, but without any ligand, isolated human SAP aggressively autoaggregates and precipitates, imposing severe constraints on methods for molecular mass determination.

Materials and Methods

Gel filtration chromatography and density gradient ultracentrifugation were used to compare SAP with the closely related molecule, C-reactive protein (CRP; which is known to be a single pentamer) and the effect of human serum albumin on SAP autoaggregation was investigated.

Results

In most physiological buffers and with the necessary absence of calcium, SAP, whether isolated or from whole serum samples, eluted from gel filtration columns clearly ahead of CRP. This is consistent with the existence of a monodisperse population of SAP decamers, as previously reported. However, in Tris/phosphate buffer, SAP was pentameric, suggesting that decamerization involved ionic interactions. On density gradients formed in undiluted normal human serum, SAP sedimented as single pentamers not complexed with any macromolecular ligand, regardless of the presence or absence of calcium. The calcium-dependent autoaggregation of isolated SAP was completely inhibited by physiological concentrations of albumin and the SAP remained pentameric.

Conclusions

Human SAP exists within serum as single uncomplexed pentamers in the presence or absence of calcium. This oligomeric assembly, thus, does not require a calcium-dependent small molecule interaction. The usual >2000-fold molar excess of albumin over SAP in plasma is apparently sufficient to keep SAP in its physiological conformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Pepys MB, Baltz ML. (1983) Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34: 141–212.

    Article  CAS  PubMed  Google Scholar 

  2. Pepys MB, Dash AC, Fletcher TC, Richardson N, Munn EA, Feinstein A. (1978) Analogues in other mammals and in fish of human plasma proteins C-reactive protein and amyloid P component. Nature 273: 168–170.

    Article  CAS  PubMed  Google Scholar 

  3. Baltz ML, de Beer FC, Feinstein A, et al. (1982) Phylogenetic aspects of C-reactive protein and related proteins. Ann. N.Y. Acad. Sci. 389: 49–75.

    Article  CAS  PubMed  Google Scholar 

  4. Woo P, Korenberg JR, Whitehead AS. (1985) Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J. Biol. Chem. 260: 13384–13388.

    PubMed  CAS  Google Scholar 

  5. Mantzouranis EC, Dowton SB, Whitehead AS, Edge MD, Bruns GAP, Colten HR. (1985) Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1. J. Biol. Chem. 260: 7752–7756.

    PubMed  CAS  Google Scholar 

  6. Emsley J, White HE, O’Hara BP, et al. (1994) Structure of pentameric human serum amyloid P component. Nature 367: 338–345.

    Article  CAS  PubMed  Google Scholar 

  7. Srinivasan N, White HE, Emsley J, Wood SP, Pepys MB, Blundell TL. (1994) Comparative analyses of pentraxins: implications for protomer assembly and ligand binding. Structure 2: 1017–1027.

    Article  CAS  PubMed  Google Scholar 

  8. Shrive AK, Cheetham GMT, Holden D, et al. (1996) Three-dimensional structure of human C-reactive protein. Nature Struct. Biology 3: 346–354.

    Article  CAS  Google Scholar 

  9. Srinivasan N, Rufino SD, Pepys MB, Wood SP, Blundell TL. (1996) A superfamily of proteins with the lectin fold. Chemtracts-Biochem. Mol. Biol. 6: 149–164.

    CAS  Google Scholar 

  10. Thompson D, Pepys MB, Wood SP. (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7: 169–177.

    Article  CAS  PubMed  Google Scholar 

  11. Pinteric L, Assimeh SN, Kells DIC, Painter RH. (1976) The ultrastructure of Clt, a subcomponent of the first component of complement: an EM and ultracentrifuge study. J. Immunol. 117: 79–83.

    PubMed  CAS  Google Scholar 

  12. Pepys MB, Dash AC, Munn EA, et al. (1977) Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet i: 1029–1031.

    Article  Google Scholar 

  13. Pinteric L, Painter RH. (1979) Electron microscopy of serum amyloid protein in the presence of calcium: alternative forms of assembly of pentagonal molecules in two-dimensional lattices. Can. J. Biochem. 57: 727–736.

    Article  CAS  PubMed  Google Scholar 

  14. Perkins SJ, Pepys MB. (1986) X-ray and neutron scattering studies on CRP and SAP. In: Peeters J (ed). Protides of the Biological Fluids, Vol. 34. Pergamon Press, Oxford, pp. 323–326.

    Google Scholar 

  15. Ashton AW, Boehm MK, Gallimore JR, Pepys MB, Perkins SJ. (1997) Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses. J. Mol. Biol. 272: 408–422.

    Article  CAS  PubMed  Google Scholar 

  16. Sørensen IJ, Andersen O, Holm Nielsen E, Svehag S-E. (1995) Native human serum amyloid P component is a single pentamer. Scand. J. Immunol. 41: 263–267.

    Article  PubMed  Google Scholar 

  17. Pepys MB. (1994) Amyloidosis. In: Frank MM, Austen KF, Claman HN, Unanue ER (eds). Samter’s Immunologic Diseases, Fifth Ed. Little, Brown and Company, Boston, pp. 637–655.

    Google Scholar 

  18. Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E. (1997) Amyloid P component. A critical review. Amyloid: Int. J. Exp. Clin. Invest. 4: 274–295.

    Article  CAS  Google Scholar 

  19. Tennent GA, Lovat LB, Pepys MB. (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer’s disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA 92: 4299–4303.

    Article  CAS  PubMed  Google Scholar 

  20. Botto M, Hawkins PN, Bickerstaff MCM, et al. (1997) Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Med. 3: 855–859.

    Article  CAS  PubMed  Google Scholar 

  21. Pepys MB, Butler PJG. (1987) Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148: 308–313.

    Article  CAS  PubMed  Google Scholar 

  22. Breathnach SM, Kofler H, Sepp N, et al. (1989) Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 170: 1433–1438.

    Article  CAS  PubMed  Google Scholar 

  23. Butler PJG, Tennent GA, Pepys MB. (1990) Pentraxin-chromatin interactions. Serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J. Exp. Med. 172: 13–18.

    Article  CAS  PubMed  Google Scholar 

  24. Hintner H, Booker J, Ashworth J, Auböck J, Pepys MB, Breathnach SM. (1988) Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. J. Invest. Dermatol. 91: 22–28.

    Article  CAS  PubMed  Google Scholar 

  25. Hind CRK, Collins PM, Baltz ML, Pepys MB. (1985) Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Biochem. J. 225: 107–111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Pepys MB. (1999) The Lumleian Lecture. C-reactive protein and amyloidosis: from proteins to drugs? In: Williams G (ed). Horizons in Medicine, Vol. 10. Royal College of Physicians, London, pp. 397–414.

    Google Scholar 

  27. Bickerstaff MCM, Botto M, Hutchinson WL, et al. (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med. 5: 694–697.

    Article  CAS  PubMed  Google Scholar 

  28. Baltz ML, de Beer FC, Feinstein A, Pepys MB. (1982) Calcium-dependent aggregation of human serum amyloid P component. Biochim. Biophys. Acta 701: 229–236.

    Article  CAS  PubMed  Google Scholar 

  29. de Beer FC, Baltz M, Holford S, Feinstein A, Pepys MB. (1981) Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J. Exp. Med. 154: 1134–1149.

    Article  PubMed  Google Scholar 

  30. Schwalbe RA, Dahlbäck B, Nelsestuen GL. (1990) Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J. Biol. Chem. 265: 21749–21757.

    PubMed  CAS  Google Scholar 

  31. Schwalbe RA, Dahlbäck B, Nelsestuen GL. (1991) Heparin influence on the complex of serum amyloid P component and complement C4b-binding protein. J. Biol. Chem. 266: 12896–12901.

    PubMed  CAS  Google Scholar 

  32. de Frutos PG, Dahlbäck B. (1994) Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. J. Immunol. 152: 2430–2437.

    Google Scholar 

  33. de Frutos PG, Härdig Y, Dahlbäck B. (1995) Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270: 26950–26955.

    Article  Google Scholar 

  34. Hawkins PN, Tennent GA, Woo P, Pepys MB. (1991) Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin. Exp. Immunol. 84: 308–316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. de Beer FC, Pepys MB. (1982) Isolation of human C-reactive protein and serum amyloid P component. J. Immunol. Methods 50: 17–31.

    Article  PubMed  Google Scholar 

  36. Pepys MB, Dash AC, Fielder AHL, Mirjah DD. (1977) Isolation and study of murine C3. Immunology 33: 491–499.

    PubMed  PubMed Central  CAS  Google Scholar 

  37. Reay P. (1982) Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay. Ann. Clin. Biochem. 19: 129–133.

    Article  CAS  PubMed  Google Scholar 

  38. Hawkins PN, Wootton R, Pepys MB. (1990) Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J. Clin. Invest. 86: 1862–1869.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Hind CRK, Collins PM, Renn D, et al. (1984) Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. J. Exp. Med. 159: 1058–1069.

    Article  CAS  PubMed  Google Scholar 

  40. Pepys MB, Dash AC, Markham RE, Thomas HC, Williams BD, Petrie A. (1978) Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin. Exp. Immunol. 32: 119–124.

    PubMed  PubMed Central  CAS  Google Scholar 

  41. Nelson SR, Tennent GA, Sethi D, et al. (1991) Serum amyloid P component in chronic renal failure and dialysis. Clin. Chim. Acta 200: 191–200.

    Article  CAS  PubMed  Google Scholar 

  42. Hohenester E, Hutchinson WL, Pepys MB, Wood SP. (1997) Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP. J. Mol. Biol. 269: 570–578.

    Article  CAS  PubMed  Google Scholar 

  43. Pepys MB, Rademacher TW, Amatayakul-Chantler S, et al. (1994) Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91: 5602–5606.

    Article  CAS  PubMed  Google Scholar 

  44. Vigushin DM, Pepys MB, Hawkins PN. (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J. Clin. Invest. 91: 1351–1357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Pepys MB. (1979) Isolation of serum amyloid P component (protein SAP) in the mouse. Immunology 37: 637–641.

    PubMed  PubMed Central  CAS  Google Scholar 

  46. Osmand AP, Friedenson B, Gewurz H, Painter RH, Hofmann T, Shelton E. (1977) Characterisation of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc. Natl. Acad. Sci. USA 74: 739–743.

    Article  CAS  PubMed  Google Scholar 

  47. Roux KH, Kilpatrick JM, Volanakis JE, Kearney JF. (1983) Localization of the phosphocholine-binding sites on C-reactive protein by immuno-electron microscopy. J. Immunol. 131: 2411–2415.

    PubMed  CAS  Google Scholar 

  48. Wood SP, Oliva G, O’Hara BP, et al. (1988) A pentameric form of human serum amyloid P component: crystallization, X-ray diffraction and neutron scattering studies. J. Mol. Biol. 202: 169–173.

    Article  CAS  PubMed  Google Scholar 

  49. Hind CRK, Collins PM, Pepys MB. (1984) Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactose. Biochim. Biophys. Acta 802: 148–150.

    Article  CAS  PubMed  Google Scholar 

  50. Booth DR, Gallimore JR, Hutchinson WL, et al. (1999) Analysis of autoaggregation and ligand binding sites of serum amyloid P component by in vitro mutagenesis. In: Kyle RA, Gertz MA (eds). Amyloid and Amyloidosis 1998. Parthenon Publishing, Pearl River, New York, pp. 23–25.

    Google Scholar 

Download references

Acknowledgments

This work was supported by Medical Research Council (U.K.) Programme Grant G97900510 to M. B. Pepys and Human Frontier Science Program Fellowship to E. Hohenester.

Author information

Author notes

  1. Winston L. Hutchinson &  Mark B. Pepys FRS

    Present address: Department of Medicine, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK

  2. Erhard Hohenester

    Present address: Biophysics Section, Blackett Laboratory, Imperial College of Science, Technology and Medicine, London, UK

Authors and Affiliations

  1. Immunological Medicine Unit, Division of Medicine, Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Winston L. Hutchinson &  Mark B. Pepys FRS

  2. Department of Crystallography, Birkbeck College, University of London, London, UK

    Erhard Hohenester

Authors
  1. Winston L. Hutchinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erhard Hohenester
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark B. Pepys FRS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark B. Pepys FRS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hutchinson, W.L., Hohenester, E. & Pepys, M.B. Human Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum. Mol Med 6, 482–493 (2000). https://doi.org/10.1007/BF03401789

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401789

Keywords

Search

Navigation